Synopsis
Synopsis
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Docatone
2. Dopram
3. Doxapram
4. Hydrochloride, Doxapram
1. 113-07-5
2. Stimulexin
3. Dopram
4. 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one Monohydrochloride
5. Doxapram Hydrochloride Anhydrous
6. Doxapram (hydrochloride)
7. Fb8713u6dm
8. 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydrochloride
9. 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-onemonohydrochloride
10. Dsstox_cid_27815
11. Dsstox_rid_82579
12. Dsstox_gsid_47837
13. Doxapramhydrochloride
14. Chebi:59837
15. Ahr-619
16. Cas-113-07-5
17. 3,3-diphenyl-1-ethyl-4-(2-morpholinoethyl)-2-pyrrolidinone Hydrochloride
18. 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone Hydrochloride Hydrate
19. 2-pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, Monohydrochloride, Monohydrate
20. Ncgc00167459-01
21. Unii-fb8713u6dm
22. Einecs 204-022-3
23. 2-pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, Monohydrochloride
24. Schembl40645
25. Mls001424142
26. Chembl1200876
27. Dtxsid9047837
28. Tox21_112463
29. Mfcd00072148
30. Nsc170958
31. Akos015906444
32. Tox21_112463_1
33. Ac-4694
34. Ccg-101076
35. Ccg-221205
36. Nc00326
37. Nsc 170958
38. Sb18933
39. 2-pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, Monohydrochloride
40. Ncgc00167459-02
41. As-13336
42. Smr000469229
43. 2-pyrrolidinone,3-diphenyl-, Monohydrochloride
44. 081d530
45. 113d075
46. J-002892
47. Q27126918
48. 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one Hydrochloride
49. (+/-)-1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone Monohydrochloride
50. 2-pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, Hydrochloride, Hydrate (1:1:1)
51. 2-pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, Monohydrochloride, (+/-)-
Molecular Weight | 415.0 g/mol |
---|---|
Molecular Formula | C24H31ClN2O2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 6 |
Exact Mass | 414.2074059 g/mol |
Monoisotopic Mass | 414.2074059 g/mol |
Topological Polar Surface Area | 32.8 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 487 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Doxapram hydrochloride |
Drug Label | DOPRAM Injection (doxapram hydrochloride injection, USP) is a clear, colorless, sterile, non-pyrogenic, aqueous solution with pH 3.5 to 5, for intravenous administration.Each 1 mL contains:Doxapram Hydrochloride, USP .................................... |
Active Ingredient | Doxapram hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 20mg/ml |
Market Status | Prescription |
Company | Bedford |
2 of 2 | |
---|---|
Drug Name | Doxapram hydrochloride |
Drug Label | DOPRAM Injection (doxapram hydrochloride injection, USP) is a clear, colorless, sterile, non-pyrogenic, aqueous solution with pH 3.5 to 5, for intravenous administration.Each 1 mL contains:Doxapram Hydrochloride, USP .................................... |
Active Ingredient | Doxapram hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 20mg/ml |
Market Status | Prescription |
Company | Bedford |
Central Nervous System Stimulants
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)
Respiratory System Agents
Drugs used for their effects on the respiratory system. (See all compounds classified as Respiratory System Agents.)
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-06-11
Pay. Date : 2018-01-26
DMF Number : 32049
Submission : 2018-01-26
Status : Active
Type : II
Certificate Number : R1-CEP 2017-084 - Rev 00
Issue Date : 2023-07-17
Type : Chemical
Substance Number : 1201
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33794
Submission : 2019-04-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6114
Submission : 1985-12-02
Status : Inactive
Type : II
Registration Number : 218MF10495
Registrant's Address : 2820 North Normandy Drive Petersburg, Virginia 23805
Initial Date of Registration : 2006-05-15
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7183
Submission : 1987-10-14
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 573
Submission : 1963-06-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Date of Issue : 2013-08-08
Valid Till : 2016-07-02
Written Confirmation Number : WC-0223
Address of the Firm :
NDC Package Code : 10920-601
Start Marketing Date : 2017-10-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
GDUFA
DMF Review : Complete
Rev. Date : 2018-06-11
Pay. Date : 2018-01-26
DMF Number : 32049
Submission : 2018-01-26
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33794
Submission : 2019-04-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6114
Submission : 1985-12-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7183
Submission : 1987-10-14
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 573
Submission : 1963-06-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
Certificate Number : R1-CEP 2017-084 - Rev 00
Status : Valid
Issue Date : 2023-07-17
Type : Chemical
Substance Number : 1201
Registration Number : 218MF10495
Registrant's Address : 2820 North Normandy Drive Petersburg, Virginia 23805
Initial Date of Registration : 2006-05-15
Latest Date of Registration : 2010-03-25
Date of Issue : 2013-08-08
Valid Till : 2016-07-02
Written Confirmation Number : WC-0223
Address of the Firm : Plot B-1 Wagle Industrial Eastate Thane W 400604 Maharashtra State
NDC Package Code : 10920-601
Start Marketing Date : 2017-10-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
About the Company : Midas Pharma is a pharmaceutical company that excels in providing extensive expertise while fostering connections between companies, individuals, and knowledge. The core competence...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : Arevipharma GmbH is a modern manufacturer of active pharmaceutical ingredients and intermediates with more than 140 years of expertise. Our customers are generic and research-based...
About the Company : Gurvey & Berry offers an impressive lineup of bulk raw materials, but we are much more than products by the kilo or tonne. With 4 decades behind us, and our Service First philosoph...
About the Company : Nhwa is specialized in manufacturing APIs and dosages in the field of Central Nervous System. With 40 years of experience and excellent reputation, Nhwa has become the leader of ma...
About the Company : Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharma...
About the Company : Synergene Active Ingredients Pvt.Ltd was incorporated in 2006 and commercial operations began in the same year. The Company is a manufacturer and supplier of Active Pharmaceuticals...
About the Company : Xi’an Libang Enterprises, established in 1996, a hi-tech biopharmaceutical-oriented corporate group specialized in the development, production and distribution of pharmaceutical ...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 110-52-1
End Use API : Doxapram Hydrochloride
About The Company : Maisuriya Pharma Solutions is a research-driven & technology-oriented company. Continuous innovations & improvement are the lifeblood of our business. Our major...
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXAPRAM HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 1992-01-30
Application Number : 73529
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXAPRAM HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2003-01-10
Application Number : 76266
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Dopram Fresenius 20mg/1ml
Dosage Form : INJ
Dosage Strength : 20mg/ml
Packaging : 20X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : RX
Registration Country : USA
Brand Name : DOPRAM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 1982-01-01
Application Number : 14879
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : Mopram
Dosage Form : INJECTION
Dosage Strength : 100MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG
Packaging : 5mL:100mgx4amps
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Related Excipient Companies
Excipients by Applications
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Tablet
Grade : Parenteral, Oral, Topical
Category : Parenteral, Solubilizers, Topical
Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral
Grade : Parenteral and Topical
Category : Parenteral, Topical
Application : Parenteral, Topical
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?